Safety, Tolerability, and Efficacy of Sofosbuvir Plus Ribavirin in Elderly Patients Infected with Hepatitis C Virus Genotype 2

By  

Digestive Diseases, Vol. 34, Iss. 6, 2016-10 ,pp. : 632-639

Karger

Access to resources Recommend Favorite

Peginterferon α-2a Combination Therapies in Chronic Hepatitis C Patients Who Relapsed After or Had a Viral Breakthrough on Therapy with Standard Interferon α-2b Plus Ribavirin: A Pilot Study of Efficacy and Safety

By Herrine Steven   Brown Robert   Bernstein David   Ondovik Michael   Lentz Ellen   Te Helen  

Digestive Diseases and Sciences, Vol. 50, Iss. 4, 2005-04 ,pp. : 719-726

Springer Publishing Company

Access to resources Recommend Favorite

Rapid virological response in peripheral blood mononuclear cells with an increase of hepatitis C virus-specific interferon-gamma production predisposes to sustained virological response in patients with chronic hepatitis C genotype 1 undergoing treatment with pegylated-interferon alpha 2a plus ribavirin

By Perrella A.   Sbreglia C.   Atripaldi L.   Esposito C.   D'Antonio A.   Perrella O.  

Scandinavian Journal of Gastroenterology, Vol. 45, Iss. 2, 2010-02 ,pp. : 250-255

Informa Healthcare

Access to resources Recommend Favorite

Swiss Multicenter Study Evaluating the Efficacy, Feasibility and Safety of Peginterferon-Alfa-2a and Ribavirin in Patients with Chronic Hepatitis C in Official Opiate Substitution Programs

By  

Digestion, Vol. 78, Iss. 2-3, 2008-11 ,pp. : 123-130

Karger

Access to resources Recommend Favorite

Retreatment with peg-interferon and ribavirin in patients with chronic hepatitis C virus genotype 2 or 3 infection with prior relapse

By Lagging Martin  

Scandinavian Journal of Gastroenterology, Vol. 48, Iss. 7, 2013-07 ,pp. : 839-847

Informa Healthcare

Access to resources Recommend Favorite